Cleopatra Hospital Co (CAI:CLHO) FFO


CAI:CLHO Cleopatra Hospital Co CAI:CLHO
88 GF Score
Price E£17.00
GF Value E£13.81
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Cleopatra Hospital Co FFO?

FFO (Funds from operations) only applies to REITs.

CAI:CLHO
88GF Score
Cleopatra Hospital Co CAI:CLHO
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cleopatra Hospital Co (CAI:CLHO) Overvalued in 2026?

Based on GuruFocus' analysis, Cleopatra Hospital Co stock appears to be overvalued. The current stock price of E£17.00 is trading 23.1% above its estimated GF Value™ of E£13.81. GuruFocus considers Cleopatra Hospital Co to be Modestly Overvalued.

Key valuation signals for CAI:CLHO:

  • FFO:
  • GF Value™: E£13.81 vs. price of E£17.00 (23.1% above fair value)
  • GF Score™: 88/100 with 5 warning signs

No single metric tells the full story. See the CAI:CLHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cleopatra Hospital Co Business Description

Address 39, 41 Cleopatra street, Heliopolis, Cairo, EGY
Cleopatra Hospital Co establishes a private hospital to provide modern health and medical services, in addition to medical care for inpatients. The company's segments include Cleopatra Hospital Company, Cairo Specialised Hospital, Nile Badrawy Hospital, Al Shrouk Hospital, CHG Medical Services, CHG Pharma for Pharmacy Management, CHG for Hospitals Company, Queens Hospital, ElKateb Hospital, Bedaya El Gedida Company for Medical Centers and Hospitals, CHG SKY Hospital, and Cleopatra Heaven.
88GF Score

Get the complete analysis for CAI:CLHO

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

E£17.00
Price
E£13.81
GF Value